Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is 3.50% vs 33.29% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is 43.40% vs -59.07% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is 5.67% vs -5.68% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is -16.22% vs -8.26% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024
Compare Quarterly Results Of Zhejiang Starry Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 3.82% vs 26.07% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 3.50% vs 33.29% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 6.29% vs 124.53% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 43.40% vs -59.07% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 5.05% vs 2,740.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 5.67% vs -5.68% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -22.50% vs -11.44% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -16.22% vs -8.26% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






